TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
林水龍LIN, SHUEI-LIONG
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
32筆
21
Lai, C. F., Cheng, C. I., Chang, C. H., Chen, Y. T., Hwang, H. C., Lin, S. L., Huang, J. W., & Huang, S. J. (2020). Integrating the Surprise Question, Palliative Care Screening Tool, and Clinical Risk Models to Identify Peritoneal Dialysis Patients With High One-Year Mortality. Journal of Pain and Symptom Management, 60(3), 613-+. https://doi.org/10.1016/j.jpainsymman.2020.03.035
22
Lee, T. H., Yeh, C. F., Lee, Y. T., Shih, Y. C., Chen, Y. T., Hung, C. T., . . . Yang, K. C. (2020). Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGF beta signaling through TGFBR1 stabilization. Nature Communications, 11(1). doi:10.1038/s41467-020-18047-x
23
Pai, C. H., Lin, S. R., Liu, C. H., Pan, S. Y., Hsu, H., Chen, Y. T., Yen, C. T., Yu, I. S., Wu, H. L., Lin, S. L., & Lin, S. W. (2020). Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis. Scientific Reports, 10(1), Article 16772. https://doi.org/10.1038/s41598-020-73194-x
24
Lin, Y. C., Lai, T. S., Wu, H. Y., Chou, Y. H., Chiang, W. C., Lin, S. L., Chen, Y. M., Chu, T. S., & Tu, Y. K. (2020). Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Clinical Pharmacology & Therapeutics, 108(4), 833-843. https://doi.org/10.1002/cpt.1859
25
Chou, Y. H., Pan, S. Y., Shao, Y. H., Shih, H. M., Wei, S. Y., Lai, C. F., Chiang, W. C., Schrimpf, C., Yang, K. C., Lai, L. C., Chen, Y. M., Chu, T. S., & Lin, S. L. (2020). Methylation in pericytes after acute injury promotes chronic kidney disease. Journal of Clinical Investigation, 130(9), 4845-4857.https://doi.org/10.1172/jci135773
26
Lin, S. T., Ma, C. C., Kuo, K. T., Su, Y. F., Wang, W. L., Chan, T. H., Su, S. H., Weng, S. C., Yang, C. H., Lin, S. L., & Yu, M. J. (2019). Transcription Factor Elf3 Modulates Vasopressin-Induced Aquaporin-2 Gene Expression in Kidney Collecting Duct Cells. Frontiers in Physiology, 10, Article 1308. https://doi.org/10.3389/fphys.2019.01308
27
Chou, Y. H., Huang, W. L., Chang, C. H., Yang, C. C. H., Kuo, T. B. J., Lin, S. L., Chiang, W. C., & Chu, T. S. (2019). Heart rate variability as a predictor of rapid renal function deterioration in chronic kidney disease patients. Nephrology, 24(8), 806-813. https://doi.org/10.1111/nep.13514
28
Chiang, W. C., Huang, Y. C., Fu, T. I., Chen, P. M., Chang, F. C., Lai, C. F., Wu, V. C., Lin, S. L., & Chen, Y. M. (2019). Angiopoietin 1 influences ischemic reperfusion renal injury via modulating endothelium survival and regeneration. Molecular Medicine, 25, Article 5. https://doi.org/10.1186/s10020-019-0072-7
29
Chen, W. Y., Wu, S. Y., Lin, T. C., Lin, S. L., & Wu-Hsieh, B. A. (2019). Human dendritic cell-specific ICAM-3-grabbing non-integrin downstream signaling alleviates renal fibrosis via Raf-1 activation in systemic candidiasis. Cellular & Molecular Immunology, 16(3), 288-301. https://doi.org/10.1038/s41423-018-0161-5
30
Lin, Y. C., Hsu, H. K., Lai, T. S., Chiang, W. C., Lin, S. L., Chen, Y. M., Chen, C. C., & Chu, T. S. (2019). Emergency department utilization and resuscitation rate among patients receiving maintenance hemodialysis. Journal of the Formosan Medical Association, 118(12), 1652-1660. https://doi.org/10.1016/j.jfma.2019.01.007
